A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
Clinical trial NCT06202261 · RECRUITING
Trial details
- NCT number
- NCT06202261
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2026-12-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.